FDA Adverse Event Injury Summary report: N

2520274-2013-061891

MDR report key: 3331104 · Received September 6, 2013

Report

Report Number
2520274-2013-061891
Event Type
Injury
Date Received
September 6, 2013
Report Date
August 8, 2013
Manufacturer
SYNTHES USA
Product Code
JDS
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

DEVICE USED FOR TREATMENT, NOT DIAGNOSIS. ARTICLE CITATION : APRIL 2011. THIS REPORT IS FOR AN UNKNOWN NAIL. THE INVESTIGATION COULD NOT BE COMPLETED; NO CONCLUSION COULD BE DRAWN AS NO PRODUCT WAS RECEIVED. WITHOUT A LOT NUMBER THE DEVICE HISTORY RECORDS COULD NOT BE REVIEWED.

Description of Event or Problem · 1

JOURNAL ARTICLE RECEIVED:FUNCTIONAL OUTCOME AFTER ANTEGRADE FEMORAL NAILING: A COMPARISON OF TROCHANTERIC FOSSA VERSUS TIP OF GREATER TROCHANTER ENTRY POINT. CHLOE ANSARI MOEIN, MD,HENK-JAN TEN DUIS, MD, PHD, LIAM OEY, MD, PHD, GERARD DE KORT, MD, WOUT VAN DER MEULEN, MD,S KARIN VERMEULEN, PHDK, AND CHRISTIAAN VAN DER WERKEN, MD, PHD.J ORTHOP TRAUMA 2011;25:196¿201. THE PROBLEM THAT OCCURRED FOR THE PATIENTS (IN BOTH GROUPS) DURING PROLONGED WALKING ALWAYS INCLUDED MUSCLE WEAKNESS AND SUBSEQUENT REDUCED ENDURANCE IN THE OPERATED LEG WITH ADDITIONAL LIMPING. ALL PATIENTS IN BOTH GROUPS HAD A HIP RANGE OF MOTION EQUAL TO THE OPPOSITE SIDE. THIS IS REPORT NUMBER 1 OF 1 FOR COMPLAINT NUMBER (B)(4). A RETROSPECTIVE CLINICAL STUDY ON THE RELATIONSHIP BETWEEN ENTRY POINT-RELATED SOFT TISSUE DAMAGE IN ANTEGRADE FEMORAL NAILING AND THE FUNCTIONAL OUTCOME IN PATIENTS WITH A PROXIMAL THIRD FEMORAL SHAFT FRACTURE. THE STUDY INCLUDE SEVENTEEN MALE PATIENTS WITH A HIGH FEMORAL SHAFT FRACTURE TREATED WITH AN ANTEGRADE FEMORAL NAIL. A MALE PATIENT AGE (B)(6) WHO HAD AN UNREAMED FEMORAL NAIL PROCEDURE HAD A POSITIVE TRENDELENBURG SIGN AND A ABNORMAL EMG WITH EVIDENCE OF ACUTE INJURY TO THE SUPERIOR GLUTEAL NERVE AFTER THE OPERATION FOLLOWED BY REINNERVATION. THIS IS REPORT NUMBER 1 OF 1 FOR COMPLAINT NUMBER (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
443045 JDS SYNTHES USA

Patients

Seq Age Sex Outcome Treatment
1 51 YR Required Intervention